SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... more than three million people in Europe.
signs and symptoms of RA include pain, stiffness and ... infection. Patients should be monitored for
signs and symptoms of infection before, during and ... receiving SIMPONI should be monitored closely for
signs and symptoms of active tuberculosis during and ...
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
... emotion, lack of interest and depressive
signs and symptoms(1). Manic symptoms of bipolar I ... Syndrome (NMS) has been reported with Zyprexa. If
signs and symptoms appear, immediate discontinuation is ... diaphoresis and cardiac dysrhythmia). Additional
signs may include elevated creatinine phosphokinase, ...
New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
... weeks experienced significant improvements in
signs and symptoms through week 24, compared with ... and showed SIMPONI to be effective in improving
signs and symptoms of RA. Eighty percent of patients ... may benefit these patients by reducing the
signs and symptoms of rheumatoid arthritis."
...
Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
... weeks provided persistent improvements in the
signs and symptoms in patients with psoriatic arthritis ... 20. At least 50 percent improvement in arthritis
signs and symptoms (ACR 50) was seen in 47 of 70 ... 100 mg experienced sustained improvements in the
signs and symptoms of psoriatic arthritis through two ...
Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients
... improvement in physical function and disease
signs and symptoms over two years. Patients received ... methotrexate experienced a reduction in disease
signs and symptoms at one year compared with patients ... a 50 or 70 percent improvement in their disease
signs and symptoms at 132 weeks, 66.7 percent (ACR50) ...
ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
... ability to effectively and conveniently treat
signs and symptoms of dry eye disease and provide fast ... study enrolled 38 patients who exhibited
signs and symptoms consistent with moderate dry eye ... bromfenac compared to baseline on the objective
signs of conjunctival staining (Lissamine Green test) ...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
... for the remote monitoring of patients' vital
signs by healthcare professionals. The new LifeShirt ... continuously collecting and fusing multiple vital
signs into a validated, actionable health ... software to fuse data from multiple vital
signs into a single index of health status that will ...
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
... active Crohn's disease for the reduction of the
signs and symptoms in patients who have an inadequate ... indications:
Reducing
signs and symptoms, inhibiting the progression of ... combination with methotrexate.
Reducing
signs and symptoms in patients with active AS.
...
Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
... Cimzia(R) is also approved for reducing
signs and symptoms of Crohn's disease and maintaining ... (FDA) has approved Cimzia (R) for reducing
signs and symptoms of Crohn's disease and maintaining ... be closely monitored for the development of
signs and symptoms of infection during and after ...
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
... selective alpha blocker for the treatment of the
signs and symptoms of BPH, produces rapid improvements ... fast acting, effective and safe treatment for the
signs and symptoms associated with BPH."
BPH is ... 923 generally healthy men ages 50 or older with
signs and symptoms of BPH, including a peak urine flow ...
ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;
... quality of life as well as in measures of dry eye
signs and symptoms. A patient registry study is ... registry study, "Effect of Lacrisert(R) on the
signs and Symptoms of Dry Eye in Contact Lens Wearers" ... and 53% experienced an improvement in dry eye
signs while wearing contact lenses. It was also ...
New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
... indicated in the U.S. for the treatment of the
signs and symptoms of idiopathic Parkinson's disease ... reported falling asleep without perceived warning
signs during activities of daily living, including ... and Drug Administration for the treatment of the
signs and symptoms of idiopathic Parkinson's disease ...
Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
... statistically significant improvement
with
signs and symptoms in patients suffering from ... effect on multiple
efficacy variables for both
signs and symptoms at Month 1 and Month 3. .
These ... new trial
demonstrating efficacy on both dry eye
signs and symptoms" said Jerome
Martinez, CEO of ...
Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium
... in improving the clinical
signs and symptoms of
rosacea.
According to the ... rosacea
sufferers hope and a way to control the
signs and symptoms of this potentially
life-disruptive ... as well as through patient assessments of
signs and
symptoms of rosacea and skin tolerance.
...
AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi
... for stroke, learn to quickly identify the warning
signs and be better prepared should they themselves or ... of a video in which Tedy describes the warning
signs of stroke. The national stroke awareness ... with stroke and educating others about warning
signs - will be posted monthly beginning January 29, ...
ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
... that ecabet sodium has the ability to treat
signs and symptoms of dry eye syndrome. Ecabet sodium ... environmental clinical trials for improvement in
signs and two successful Phase III controlled chamber ... of a lower strength of Xibrom to treat the
signs and symptoms of dry eye disease in the first half ...
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
... severe disorganized or catatonic behavior. These
signs and symptoms are
associated with marked social or ... of
schizophrenia consist of characteristic
signs and symptoms that have been
present for a ... (NMS) has been reported with
olanzapine. If
signs and symptoms appear, immediate discontinuation ...
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
... be monitored carefully, and any patient with
signs or symptoms consistent with cardiac failure ... should be weighed and monitored regularly for
signs and symptoms of edema, which can be serious or ... Physicians and patients should remain alert for
signs and symptoms of GI ulceration and hemorrhage and ...
Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
... that grape intake lowered blood pressure and
signs of
heart muscle damage, and improved heart ... throughout their bodies, and fewer
signs of heart muscle
damage than the rats that ate the ... unit of time.
The researchers also looked for
signs of inflammation, oxidative damage
and other ...
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
... Patients were assessed for improvement in
signs and symptoms of
RA. The primary endpoint for the ... together with methotrexate in the treatment of
signs and
symptoms and in the prevention of joint ... Patients were assessed for improvement in
signs and symptoms of
RA. The primary endpoint of the ...
New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
... methotrexate experienced a
reduction in disease
signs and symptoms at one year compared with ... with ACTEMRA
experienced an improvement in the
signs and symptoms of RA and achieved
remission ... improvement in
physical function and disease
signs and symptoms. Patients received either
ACTEMRA
...
ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
... (RA) achieved significant improvements in
signs and
symptoms when treated with ACTEMRA(R) ... achieved a 20 percent
reduction (ACR20)(1) in RA
signs and symptoms, compared with 10 percent ... new treatment option for
managing the chronic
signs and symptoms of this debilitating disease."
The ...
Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
... by early
preclinical study results showing
signs of efficacy in inflammatory bowel
disease targets ... larazotide acetate was well tolerated and showed
signs of efficacy in
preventing immunologic changes ... effects observed on
intestinal permeability,
signs and symptoms. Clinical findings included:
-- ...
CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients
... on April 22, 2008 for reducing
signs and symptoms of
moderate to severe Crohn's ... CIMZIA
was approved in April 2008 for reducing
signs and symptoms of Crohn's
disease and maintaining ... CIMZIA. Monitor patients receiving CIMZIA for
signs and
symptoms of active tuberculosis, including ...
New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
... active Crohn's disease
for the reduction of the
signs and symptoms in patients who have an
inadequate ... for the following indications:
-- Reducing
signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- Reducing
signs and symptoms in patients with active AS. -- ...
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
... Colombel.
CIMZIA is approved for reducing the
signs and symptoms of Crohn's
disease and maintaining ... CIMZIA
was approved in April 2008 for reducing
signs and symptoms of Crohn's
disease and maintaining ... CIMZIA. Monitor patients receiving CIMZIA for
signs and
symptoms of active tuberculosis, including ...
QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
... significantly improves a broad range of clinical
signs of
vulvovaginal atrophy, including petechiae, ... of treatment, the mean
scores for common clinical
signs of vaginal atrophy were decreased by ... evident at
week 4, as the mean scores of all
signs were significantly decreased by
Ophena(TM) when ...
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
... of
Betaseron by patients with the earliest
signs of MS. Two-thirds of patients
(67 percent) in the ... Betaseron
treatment in patients with the earliest
signs of the disease delayed the
progression to CDMS ... population of patients with the
earliest
signs of MS, including patients with mono- or ...
NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
... developing as a drug for the treatment of the
signs and symptoms of
osteoarthritis.
NicOx' phase 3 ... efficacy of new drugs for the treatment of the
signs and
symptoms of osteoarthritis.
The main ... phase
3 clinical studies for the treatment of the
signs and symptoms of
osteoarthritis, with final phase ...
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
... No clinically significant decreases in
vital
signs were observed and all patients recovered ... of schizophrenia consist of characteristic
signs and
symptoms that have been present for a ... of time during a
one-month period, with some
signs of the disorder persisting for at least
six ...
First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting
... action for Hispanic families to watch for early
signs of AD among
their loved ones and speak with a ... often, Hispanics dismiss the symptoms of AD as
signs of normal
aging and wait years before consulting ... with Hispanic patients to start screening
for
signs of dementia at a younger age, potentially at 55 ...
Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
... Syndrome (PDSS), which describes a range
of
signs and symptoms such as sedation, delirium, ... of schizophrenia consist of characteristic
signs and
symptoms that have been present for a ... of time during a
one-month period, with some
signs of the disorder persisting for at least
six ...
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
... (MTX)
experienced significant improvements in the
signs and symptoms of
rheumatoid arthritis (RA) as well ... MTX achieved at least 20 percent
improvement in
signs and symptoms of RA (ACR 20), compared to 33 ... combination with MTX experienced improvement in
signs and symptoms of
arthritis as well as in disease ...
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
... as well as total neuropathy score (TNS) to assess
signs and
symptoms of the condition. A quantitative ... and TNS to quantify neurologic exam and assess
signs and symptoms of
the condition.
For each subject ... expression of stem cell-specific markers.
The
signs and symptoms of diabetic peripheral neuropathy ...
NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
... to assess
naproxcinod's efficacy in relieving the
signs and symptoms of
osteoarthritis of the hip and ... as an
investigational drug for treating the
signs and symptoms of osteoarthritis.
Naproxcinod is ... the efficacy of drugs for
treating the
signs and symptoms of osteoarthritis and the same as ...
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
... Abbott.
HUMIRA is indicated for reducing
signs and symptoms and inducing and
maintaining ... therapy. HUMIRA is indicated for reducing
signs and symptoms
and inducing clinical remission in ... HUMIRA is also approved by
the FDA for reducing
signs and symptoms, inducing major clinical ...
Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease
... alpha) antibody approved for reducing
signs and symptoms of Crohn's
disease and maintaining ... Monitor patients receiving
Cimzia(R) for
signs and symptoms of active tuberculosis, including ... be closely monitored for
clinical and laboratory
signs of active HBV infection throughout therapy
and ...
New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
... for the following indications:
-- Reducing
signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- Reducing
signs and symptoms in patients with active AS. -- Reducing
signs and symptoms and inducing and maintaining ...
Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
... clinical improvement. Patient assessments
of
signs and symptoms of rosacea and skin tolerance were ... that provide
sustained relief of its principal
signs and symptoms.
Dr. Arisa Ortiz from the ... burning, stinging, and dryness, all of which are
signs and
symptoms associated with acne rosacea. ...
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
... offers another
treatment option to help improve
signs and symptoms of this serious disease
in pediatric ... statement is: ORENCIA
is indicated for reducing
signs and symptoms, inducing major clinical
response, ... About ORENCIA
ORENCIA is indicated for reducing
signs and symptoms, inducing major
clinical response, ...